- Home
- FINS vs CYRX Comparison
FINS vs CYRX Comparison
Compare FINS & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FINS | CYRX |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.4M | 421.6M |
| IPO Year | 2018 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FINS | CYRX |
|---|---|---|
| Price | $13.09 | $8.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.83 |
| AVG Volume (30 Days) | 56.3K | ★ 308.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.68 |
| Revenue | N/A | ★ $228,385,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.12 |
| P/E Ratio | ★ N/A | $4.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.21 | $4.63 |
| 52 Week High | $13.64 | $11.45 |
Technical Indicators
Market Signals| Indicator | FINS | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.34 | 41.98 |
| Support Level | $13.06 | $8.16 |
| Resistance Level | $13.24 | $9.31 |
| Average True Range (ATR) | 0.09 | 0.42 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 32.50 | 69.51 |
Price Performance
Historical ComparisonAbout FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.